Related by context. All words. (Click for frequent words.) 80 Generic Version 79 Expanded Indication 79 NDA Submission 77 Migraine Drug 77 IND Filing 77 Mylan Receives Approval 77 Psoriasis Drug 77 FDA Accepts 77 Gout Drug 77 Submits NDA 76 Resubmission 76 FDA Approvals 76 Milestone Payment 76 Epilepsy Drug 76 Patient Enrollment 76 Generic Version Of 76 Generic Versions 75 Schizophrenia Drug 75 Taro Receives 75 Fast Track Status 75 FDA Approvable Letter 75 Receives Approvable Letter 75 Arthritis Drug 75 Meets Primary Endpoint 75 Lupus Drug 74 Clinical Trial Data 74 Phase IIb Trial 74 Phase 2a Trial 74 Confirmatory Phase 74 Inhaled Insulin 74 Phase III Clinical Trial 74 ANDA Filing 74 Blood Pressure Drug 74 Testosterone Gel 74 Investigational Compound 74 Announces Tentative Approval 74 Phase 1b Clinical Trial 74 Osteoporosis Drug 74 Pivotal Trial 73 Drug Candidate 73 Prostate Cancer Vaccine 73 Clinical Trial Results 73 Lung Cancer Drug 73 Treated Patients 73 IND Application 73 Tezampanel 73 Cholesterol Drug 73 Phase IIb Clinical Trial 73 Completes Patient Enrollment 73 Single Dose 73 Clinical Trial Enrollment 73 Auxilium Pharma 73 Receives Orphan Drug Designation 73 Phase 2a Clinical Trial 72 Dose Ranging Study 72 Pivotal Phase III 72 Files IND 72 Weight Loss Drug 72 Phase 2b Clinical Trial 72 Rheumatoid Arthritis Drug 72 Million Milestone Payment 72 Cholesterol Lowering Drug 72 Kidney Transplant Patients 72 First Patient Enrolled 72 Supplemental Biologics License Application 72 Sagent Pharmaceuticals Announces 72 Milestone Payments 72 Phase 2b Trial 72 Generic Protonix 72 Generic Lovenox 72 Receives Orphan Drug 71 Febuxostat 71 VIVITROL ® 71 Files Investigational 71 JAK Inhibitor 71 Phase III Trials 71 Extended Release 71 Approvable 71 Drug Coated Stent 71 Stronger Warnings 71 First Patient Treated 71 Drug Fails 71 Initiates Enrollment 71 Anti Inflammatory Drug 71 Montelukast 71 Pivotal Phase 71 Seasonal Influenza Vaccine 71 Eszopiclone 71 Initiate Phase 71 Maleate 71 GRAS Status 71 Milestone Payment From 71 Granted Orphan Drug 71 Ephedra Ban 71 Heartburn Drugs 71 Capsules CII 71 Bepreve TM 70 Pivotal Clinical Trial 70 Phase 2b Study 70 Submits Biologics License Application 70 Schizophrenia Treatment 70 Phase III Clinical Trials 70 Patient Enrolment 70 Investigational Drug 70 Initiates Phase III 70 Positive Opinion 70 Tentative Approval 70 Phase III Trial 70 Transcept Pharmaceuticals 70 Regeneron Pharma 70 Authorized Generic 70 Immunomedics Announces 70 Accelerated Approval 70 BioElectronics Announces 70 FDA Panel Recommends 70 Risperidone Oral Solution 70 Employment Inducement Awards 70 Nasdaq Delisting Notice 70 Fungal Infections 70 Prolongs Survival 70 Successfully Completes Phase 70 Aztreonam Lysine 70 Initiate Phase III 70 Investigational Treatment 70 Audited Financials 70 Expedited Review 70 Teva Provides Update 70 Romiplostim 70 Pharmacokinetic Study 70 Ranolazine 70 Patent Infringement Litigation 70 Act PDUFA date 70 Release Capsules 70 Mg Usa 70 Chemotherapy Regimen 70 Marketing Authorisation Application 70 Receives Fast Track 70 Novel Antibiotic 70 BRILINTA 70 Anemia Drug 70 Oral Calcitonin 70 Receives Complete Response 70 Erectile Dysfunction Drug 69 Dose Escalation 69 ONGLYZA TM 69 Anika Therapeutics 69 Demonstrates Significant 69 Metformin HCl 69 Combination Treatment 69 Study Evaluating 69 Sunesis Pharma 69 Mln Share Buyback 69 Initiates Clinical Trial 69 Intravenous Formulation 69 Proxy Proposals 69 Demonstrates Positive 69 See CLINICAL PHARMACOLOGY 69 Desvenlafaxine Succinate 69 Investigational Agent 69 Phase Ib Clinical Trial 69 Marketing Authorisation 69 Statin Drugs 69 Hydrochlorothiazide Tablets 69 Pivotal Study 69 Antidepressant Drug 69 Receives Tentative Approval 69 balsalazide disodium Capsules 69 Oxcarbazepine 69 Testosterone Patch 69 Silicone Breast Implants 69 BioDelivery Sciences 69 Velaglucerase Alfa 69 Flamel Technologies Announces 69 PRN FDA Approves 69 Tablet Formulation 69 Faropenem 69 Blood Thinner 69 Dexilant 69 Study Showed 69 Nasdaq Deficiency Notice 69 Optimer Pharma 69 Adjuvant Treatment 69 Patients Enrolled 69 Salix Pharma 69 Complete Response 69 Combination REOLYSIN R 69 Demonstrates Potent 69 Topline Results 69 Orapred ODT 69 Demonstrates Efficacy 69 Transdermal Patch 69 Preliminary Injunction Against 69 Rotavirus Vaccine 69 Arthritis Drugs 69 Pooled Analysis 69 Xyzal R 69 Shows Efficacy 69 Neoadjuvant Chemotherapy 69 Clinical Trial Evaluating 69 Biologic License Application 69 Revises FY# Outlook 69 HCl Injection 69 Treatment Naïve 69 STELARA TM 69 NASDAQ Delisting Notice 69 Anemia Drugs 69 Preclinical Data 68 OSMOPREP TM 68 Low Dose 68 Data Suggest 68 Diabetic Nephropathy 68 Cholesterol Drugs 68 Divalproex Sodium 68 Ondansetron Injection USP 68 Efficacy Results 68 Asthma Treatment 68 Regulatory Clearance 68 Improves Survival 68 Toremifene 68 FDA APPROVES 68 PRAECIS PHARMACEUTICALS INCORPORATED 68 First Patient Dosed 68 Pulmonary Arterial Hypertension 68 Initiates Clinical 68 Glatiramer Acetate 68 Lilly Cymbalta 68 ARIXTRA R 68 Advanced Melanoma 68 Potent Antiviral Activity 68 Clinically Tested 68 mg Tablets 68 Anti Clotting Drug 68 Randomized Clinical Trial 68 Receive Milestone Payment 68 Drug Maker 68 Cervical Cancer Vaccine 68 Effectively Treats 68 Oral Solution 68 Investigational Oral 68 Lifts FY# Outlook 68 #k Clearance 68 Anti Nausea 68 Oral Fingolimod 68 Myeloma Patients 68 Lung Cancer Trial 68 Shows Promising 68 Nicotine Vaccine 68 Inspire Pharma 68 TOPAMAX R 68 Backs FY# View 68 Fondaparinux 68 Nasdaq Delisting 68 Tablets #mg [002] 68 Clinical Trials Update 68 balsalazide tablet 68 STERIS Corporation Announces 68 Stock Buyback Plan 68 Roche Actemra 68 Liver Toxicity 68 Voluntary Withdrawal 68 Launches Generic Version 68 Submits Supplemental 68 Long Term Efficacy 68 Receives CE Marking 68 Shingles Vaccine 68 SFDA Approval 68 Adjunctive Therapy 68 Severe Sepsis 68 Orphan Status 68 GATTEX TM 68 Aflibercept 68 Double Blind Placebo 68 Survival Benefit 68 RhuDex 68 Tipranavir 68 Heart Stents 67 FDA Okays 67 Receives Positive Opinion 67 CHMP Opinion 67 Tasigna nilotinib 67 AstraZeneca Symbicort 67 Nasdaq Delisting Notification 67 DOR BioPharma Announces 67 Pneumococcal Vaccine 67 Completes Enrollment 67 Levetiracetam Tablets 67 Present Preclinical Data 67 Javelin Pharma 67 Topical Cream 67 VIVUS Announces 67 Bivalirudin 67 NASDAQ Listing Requirements 67 Fewer Side Effects 67 Reaffirms FY# Guidance 67 InNexus Biotechnology 67 Patent Lawsuit Against 67 Loceryl ® 67 COLAZAL R 67 Mycophenolate Mofetil 67 Initiates Clinical Trials 67 Novel Oral 67 Lubiprostone 67 Clinical Study Shows 67 FDA Advisory Panel 67 Breast Cancer Recurrence 67 Cinacalcet 67 Announcement acc 67 PROTONIX 67 JAK2 Inhibitor 67 CEPHALON 67 Initiate Clinical Trial 67 Colorectal Cancer Patients 67 Patent Filings 67 Soriatane 67 Bupropion HCl ER 67 Nuvelo Announces 67 Morphine Sulfate 67 Pediatric Exclusivity 67 Prostate Cancer Patients 67 Extended Release Capsules 67 Patent Infringement Suit 67 Recombinant Human 67 INTUNIV TM 67 Demonstrates Sustained 67 Plaque Psoriasis 67 Iloperidone 67 ONGLYZA ™ 67 Anti Tumor 67 Diamyd Medical Diamyd 67 FDA Clears 67 Topical Treatment 67 Product Monograph 67 Contaminated Heparin 67 Peginterferon Alfa 2a 67 Package Insert 67 LibiGel ® 67 Systemic Delivery 67 Sodium Injection 67 Key Milestones 67 Arno Therapeutics 67 liver resection surgeries 67 Recommends Approval 67 Previously Disclosed 67 Sustained Release 67 FDA Clearance 67 markets HP Acthar 67 Nasdaq Notice Regarding 67 Tylenol Recall 67 Significantly Reduced 67 Treat Anemia 67 Levoleucovorin 67 Delayed Release 67 Somaxon Pharmaceuticals 67 Protease Inhibitor 67 Orphan Designation 67 Drug Combo 67 Liver Damage 67 Sumatriptan Succinate 67 Earns Milestone Payment 67 Surgical Mesh 67 Receives Tentative FDA 67 Oral Insulin 67 Betaferon R 67 Presents Positive 67 NexMed Receives 67 Hepatitis B Vaccine 67 Glufosfamide 67 Unfractionated Heparin 67 Vioxx Successor 67 Weight Loss Supplement 67 PENTASA 67 Randomized Phase 67 Liprotamase 67 markets COLAZAL 67 Initiates Phase II 67 Grants Orphan Drug 67 rasagiline tablets 67 Hormone Refractory Prostate Cancer 67 Pegloticase 67 Backs FY# Guidance 66 Mln Stock Buyback 66 Dividend Quick Facts 66 Diet Pill 66 Ambrisentan 66 Smallpox Vaccine 66 NOVAVAX 66 Genetically Modified Salmon 66 SHIRE PLC 66 Revises FY# Guidance 66 Anadys Pharma 66 DAYTRANA TM 66 Anticancer Activity 66 Angiox ® 66 Topical Gel 66 Submits Response 66 Demonstrate Significant 66 include Phenoptin TM 66 octreotide acetate 66 Placebo Controlled Trial 66 PDL BioPharma Announces 66 Phase III Pivotal 66 Pafuramidine 66 Inhalation Aerosol 66 Brentuximab Vedotin SGN 66 Ecallantide 66 NASDAQ Deficiency Notice 66 Pivotal Phase II 66 Unsolicited Proposal From 66 FY# EPS View 66 Xenazine ® 66 Product Characteristics 66 Versus Placebo 66 Zenpep 66 HCV Protease Inhibitor 66 Drug Approvals 66 vapreotide acetate 66 Reaffirms FY# Outlook 66 Anticancer Drug 66 Indevus Pharma 66 Oncology Compounds 66 Sapacitabine 66 #mg Tablets [002] 66 Extended Release Tablets 66 Showed Significant 66 Ticagrelor 66 Desloratadine 66 Posaconazole 66 Metastatic Melanoma 66 Antitumor Activity 66 Treatment Regimen 66 Carbidopa Levodopa 66 Significantly Improved 66 Slow Progression 66 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 66 VISICOL R 66 Million Doses 66 Pivotal Trials 66 OSI Pharma 66 Bazedoxifene 66 ZEGERID Capsules 66 Trelstar R 66 Tablets USP 66 TRANSDUR ™ 66 Vaccine Adjuvant 66 therefore therapeutically equivalent 66 fluvoxamine maleate 66 Crofelemer budesonide foam 66 aripiprazole Abilify 66 Zegerid OTC 66 COVIDIEN 66 BioElectronics Corporation Announces 66 Biomarker Study 66 Halozyme Therapeutics 66 Fluticasone Propionate 66 CyDex Pharmaceuticals 66 Pain Relievers 66 Fentanyl Patch 66 Shareholder Meeting Date 66 Medoxomil 66 Beta Blocker 66 Ramelteon 66 Tesamorelin 66 Patients Treated With 66 Momenta Pharma 66 Mycamine 66 OMNARIS Nasal Spray 66 Amgen Nplate 66 Ondansetron Orally Disintegrating Tablets 66 miconazole Lauriad R 66 BioSante Pharmaceuticals Announces 66 HCl capsules 66 Lifts FY# Guidance 66 Backs FY# Forecast 66 Gene Therapy Trial 66 Desvenlafaxine 66 Silodosin 66 Alexion Soliris 66 Oral Spray 66 Resubmit 66 Aldara ® 66 SPRYCEL ® 66 Anticancer Compound 66 Cethromycin 66 R lenalidomide 66 Anticoagulant 66 Bayer Onyx 66 Pandemic Influenza Vaccine 66 Double Blind Randomized 66 TriCo Bancshares Announces 66 Plus Ribavirin 66 Somaxon Pharma 66 Second Pivotal Phase 66 Vion Pharmaceuticals 66 Demonstrated Significant 66 Pazopanib 66 Angiotech Pharma 66 pioglitazone hydrochloride 66 Ebola Vaccine 66 Gets FDA Clearance 66 Poniard Pharmaceuticals Announces 66 Eltrombopag 66 Fulvestrant 66 carbamazepine phenobarbital phenytoin rifampin 66 Statistically Significant 66 Drug Shows Promise 66 Randomized Controlled Trials 66 BioMarin Pharma 66 MOVIPREP R 66 Product Designation 66 Pirfenidone 66 Cypher Sirolimus 66 Phase IIa Clinical Trial 66 Lamotrigine 66 NYSE Amex Listing 66 Amlodipine Besylate 66 Drug Eluting Stent System 66 hydrochloride tablets 66 NovaDel Pharma 66 Novel Compound 66 Boxed Warnings 66 Immunosuppressant 66 Lifts FY# View 66 RNAi Therapeutics 66 methylnaltrexone bromide 66 Rheumatoid Arthritis Patients 65 II Clinical Trial 65 Biotech Firm 65 Lexapro Effexor Serzone 65 Transdermal System 65 Hepatitis C Treatment 65 Unsolicited Tender Offer 65 Osteoporosis Drugs 65 Initiate Phase II 65 Novel Inhibitor 65 Submits Investigational 65 Glucophage XR 65 Sprycel dasatinib 65 FDA Anti Infective 65 Levocetirizine 65 Combo Therapy 65 Hsp# Inhibitor 65 lexidronam injection 65 Backs FY# Outlook 65 Xolegel 65 Noven Pharma 65 FDA Orphan Drug 65 Hip Implants 65 Adjuvant Chemotherapy 65 Receives Milestone Payment 65 Release Tablets 65 Novel Mechanism 65 Stavzor 65 Calcium Acetate 65 Stereotaxis Announces 65 Begin Clinical Trials 65 Mg Uk 65 Vitrasert R 65 BYETTA ® 65 Epilepsy Drugs 65 Esomeprazole 65 PPD Declares 65 Projected Release Date 65 Interferon Beta 65 Lipid Lowering 65 Vimpat R 65 Osteoporosis Treatment 65 Certolizumab 65 Augment ™ 65 Focalin XR R 65 Balance Sheet Restructuring 65 #mg Tablets [001] 65 Serious Side Effects 65 R memantine HCl 65 Nitazoxanide 65 BIOLASE Announces 65 Neurocrine Biosciences Announces 65 Salix Pharmaceuticals Announces 65 Antitumor 65 Idera Pharma 65 LENALIDOMIDE 65 Generic Lipitor 65 Acute Attacks 65 Randomized Clinical Trials 65 Cholesterol Lowering 65 Treatment Resistant 65 Sanctura XR 65 Microwave Ablation System 65 Sangamo BioSciences Announces 65 Terbinafine 65 Metabasis Therapeutics 65 Corneal Transplant 65 Oral Cladribine 65 Multiple Myeloma Patients 65 Enlarged Prostate 65 Idenix Pharma 65 Alnylam Pharma 65 metformin HCl 65 Postmenopausal Osteoporosis 65 FDA Complete Response 65 Parathyroid Hormone 65 Resistant Hypertension 65 Ariad Pharma 65 Nanophase Announces 65 Alvine Pharmaceuticals 65 Methylphenidate Transdermal System 65 Adverse Event 65 Vicriviroc 65 Peregrine Pharma 65 1mg 2mg 65 Intravitreal 65 Novel Therapies 65 Paliperidone Palmitate 65 Hematological Cancers 65 Monotherapy 65 Axid 65 Golimumab 65 PROVENGE ® 65 BioSante Pharmaceuticals Reports 65 Antiplatelet 65 Insulin Pen 65 Initiates Phase 2b 65 Interferon beta 1a 65 Muraglitazar 65 highly purified pasteurized 65 DEXILANT 65 Xcytrin R 65 Therapeutic Competitors Companies 65 Demonstrates Statistically Significant 65 Lupus Nephritis 65 Anidulafungin 65 Dementia Related Psychosis 65 Shows Statistically Significant 65 Acute Heart Failure 65 MorphoSys AG MorphoSys 65 Generic Levitra Vardenafil 65 Stockholder Vote 65 #mg #mg #mg [001] 65 Lifts FY# Forecast 65 Patent Issuance 65 topical gel formulation 65 Fabry Disease 65 GeoMet Announces 65 Seasonal Flu Vaccine 65 Begins Dosing 65 Biologic Drugs 65 Inhalation Solution 65 Randomized Double Blind 65 TO AVOID PREGNANCY WHILE 65 GENERIC SILDENAFIL SOFT Generic 65 Orally Disintegrating 65 Patent Covering 65 Primary Efficacy Endpoint 65 Influenza Vaccine Production 65 R# #mg BID 65 Pharmos Corporation 65 Smooth Muscle 65 Oracea R 65 Presents Preclinical Data 65 Newly Diagnosed Patients 65 Feraheme ® 65 Onyx Pharma 65 Ridaforolimus 65 Improved Survival 65 k Premarket Notification 65 Lowers FY# Outlook 65 Peginterferon alfa 2b 65 NGSX 65 Previously Treated 65 Ciclesonide 65 Going Concern Qualification 65 Ltd Therapeutic Competitors 65 Acne Drug 65 Dupuytren Contracture 65 Embolic Protection 65 Drug Application 65 Biogen Elan 65 Controlled Study 65 Appears Safe 65 Weight Loss Pill 65 CIP TRAMADOL ER 65 Stock Buyback Program 65 nasal calcitonin product 65 Clinical Evaluation 65 Sanofi Acomplia 65 HDAC Inhibitor 65 Aurora Kinase 65 Avian Flu Vaccine 65 inhalation aerosol 65 PDUFA Prescription Drug 65 Issues Complete Response 65 Spears Conservatorship 65 Lansoprazole 65 Strategic Alternatives Review 65 Therapeutic Vaccine 65 Patent Lawsuit 65 pantoprazole sodium 65 Pediatric Patients 65 Blood Thinning 65 Nonprescription 65 Creditor Protection 65 Advisers Urge 65 Amylin Pharma 65 OxyContin Maker 65 Bicalutamide 65 XPEL Announces 65 Improve Survival 65 Alnylam Nasdaq ALNY 65 adenosine injection 65 ZEGERID Chewable Tablets 65 Prophylactic Treatment 65 Vildagliptin 65 Purported Class 65 #M Buyback [001] 65 Receptor Agonist 65 Migraine Treatment 65 Multiple Ascending Dose 65 Varespladib 65 SABER ™ 65 Dose Ranging 65 FDA Issues Approvable 65 Haemophilus b Conjugate 65 Knee Osteoarthritis 65 Atomoxetine 65 Resale Registration Statement 65 Boceprevir 65 Issued Patent 65 Medicure Announces 65 FY# Guidance 65 UCB Keppra 65 Ustekinumab 65 granted Ortec 65 Romidepsin 65 Cites Positive 65 Dyloject TM 65 Winmark Corporation Announces 65 Commences Phase 65 Achieves Primary Endpoint 65 Million Stock Buyback 65 Anticancer Agent 65 Threshold Pharma 65 ACADIA Pharmaceuticals 65 Bladex Announces 64 DOV Pharmaceutical 64 Sinus Infections 64 Levofloxacin 64 Oral Mucositis 64 Formoterol 64 Crowflight Announces 64 Zorbtive TM 64 PROMUS Element Everolimus Eluting 64 SinuNase TM 64 AZASAN R 64 NASDAQ Delisting 64 Bosutinib 64 Fixed Dose 64 Pharmacyclics Announces 64 Complicated Skin 64 #mg #mg #mg [003] 64 Teikoku Pharma USA 64 FDA approvable letter 64 Interferon Gamma 64 Panzem R 64 Marketing Authorisation Application MAA 64 Orphan Drug Status 64 Spectrum Pharmaceuticals Announces 64 Keppra ® XR 64 #mg #mg [002] 64 FDA Approves Expanded 64 Azathioprine 64 Dasatinib 64 Ranexa R 64 Atypical Antipsychotics 64 Treatment Reduces 64 Nationwide Voluntary Recall 64 Atypical Antipsychotic 64 FACTIVE R gemifloxacin 64 Frova ® 64 Efficacious 64 ORENCIA R 64 DORIBAX 64 Miraculins Announces 64 Renal Impairment 64 Aloxi ® 64 Keryx Biopharma 64 Patients Receiving 64 Combunox 64 Silicone Implants 64 Partial Onset Seizures 64 Strengthened Balance Sheet 64 Gene Variant 64 Nasdaq Listing Requirements 64 Isis Pharma 64 Fortical R 64 Controlled Release Tablets 64 Injection Site 64 Significant Milestones 64 Controlled Trial 64 Tigecycline 64 REG1 Anticoagulation System 64 Disease Modifying 64 Unsolicited Proposal 64 Galantamine 64 Synthetic Peptide 64 Trial Evaluating 64 NUEDEXTA ™ 64 Genetic Mutation 64 Symptom Relief 64 Fluticasone 64 Aliskiren 64 Mometasone Furoate 64 Horizant ™ 64 FY# EPS Forecast 64 Genetically Engineered Salmon 64 KV Pharma 64 5 HT3 antagonist 64 Newmont Declares Regular 64 #M Stock Buyback 64 Stock Repurchase Plan 64 Renvela ® 64 Trobalt 64 Clinical Outcome 64 Advanced Prostate Cancer 64 Emisphere Technologies 64 Levaquin levofloxacin 64 ZEVALIN ® 64 Emollient Foam 64 Webcast Discussion 64 Sanvar R 64 Dalbavancin 64 Confirms Patent 64 Neupro R 64 FDA Approval 64 Methylnaltrexone 64 adalimumab Humira 64 Invasive Fungal Infections 64 Antiepileptic 64 PHASE III 64 Dabigatran etexilate 64 Drug Eluting Coronary Stent 64 Melphalan 64 Qutenza TM 64 Fluconazole 64 Migraine Pain 64 Pain Medications 64 Patent Invalid 64 Cold Medicines 64 PEGINTRON TM 64 Improves Outcomes 64 capsules USP 64 Antiviral Activity 64 Britney Spears Conservatorship 64 Initiated Phase 64 Aeolus Pharmaceuticals Announces 64 Multaq dronedarone 64 Full Prescribing Information 64 MMR Vaccine 64 Authorized Generics 64 Virco Announces 64 Kepivance 64 Develop Novel 64 Interferon beta 1b 64 Proven Effective 64 Cyclacel Pharmaceuticals 64 Insulin Glargine 64 Tanezumab 64 Patent Ruling 64 Kaydon Corporation Announces 64 BLP# Liposome Vaccine 64 ALVESCO R 64 Antiepileptic Drug 64 Patent Infringement Suit Against 64 Testosterone MDTS ® 64 Itraconazole 64 Platelet Inhibition 64 Raptiva R 64 MKC# MKC# PP 64 NOXAFIL 64 Evista raloxifene 64 Cheap Generic 64 Renal Cell Carcinoma 64 Janssen Risperdal 64 prucalopride 64 ACE Inhibitors 64 Ercole Biotech 64 Lanthanum Carbonate 64 Par Pharma 64 guanfacine extended release 64 TYGACIL 64 JZP 64 Soriatane R 64 KEMET Announces 64 Focalin XR ® 64 Xibrom TM 64 Protalix BioTherapeutics 64 Cubist Pharma 64 Fourth Quarter Cash Dividend 64 Rotavirus Vaccines 64 Marketing Authorization Application 64 COLAZAL ® 64 lucinactant 64 Liver Transplant Patients 64 naproxen esomeprazole magnesium 64 PLAVIX ® 64 Capsules USP 64 Indomethacin 64 Moxifloxacin 64 PrandiMet 64 Regenerative Cells 64 Ropinirole 64 Announces FDA Clearance 64 Filing Status 64 Ovidrel 64 Patent Infringement Lawsuit 64 Ocrelizumab 64 Bevacizumab 64 FOLOTYN ® 64 Stent Coating 64 Sirolimus Eluting 64 Cellegesic 64 Increased Mortality 64 Biogen Idec Elan 64 Alpha interferons including 64 BUPHENYL R 64 clopidogrel bisulfate 64 Tacrolimus 64 Patent Broadly Covering 64 Regains NASDAQ 64 Civacir 64 Endeavor Drug Eluting 64 #M Buyback [002] 64 REBETOL combination therapy 64 Phase III Pivotal Trial 64 Common Share Repurchase Program 64 Oracea ® 64 SYCREST 64 Tanespimycin 64 ULTRASE 64 Wyeth Pristiq 64 GTC recombinant form 64 Silicone Breast Implant 64 Predict Risk 64 Lung Cancer Patients 64 #.#mg #mg 64 FDA Cracks Down 64 Artery Disease 64 Budesonide 64 Wizzard Software Announces 64 ALVESCO ® 64 Aromatase Inhibitors 64 Commonly Prescribed 64 metoprolol succinate 64 Unapproved Drugs 64 AVI BioPharma Announces 64 Personalized Immunotherapy 64 Eurand NV EURX 64 Luveniq 63 Known hypersensitivity 63 Option Grants 63 Novel Protein 63 Anti Tumor Activity 63 Metabolic Disorder 63 Favorable Ruling 63 Therapeutic Competitors Report 63 Boxed Warning 63 tablets USP 63 ARCALYST R 63 Issues Shareholder 63 Xenonics Announces 63 Alogliptin 63 RECOTHROM R 63 Orally Disintegrating Tablets 63 VIVUS VVUS 63 Treatment Experienced 63 Application MAA 63 Univest Corporation Declares 63 Bare Metal Stent 63 LEVADEX TM 63 Bone Fracture 63 Pfizer Lyrica 63 Annual Meeting Date 63 Paragraph IV Notice 63 Ziprasidone 63 Calcium Vitamin D 63 Catapres 63 Infected Patients 63 Enhanced Version 63 Delayed Release Tablets 63 Tamsulosin 63 Randomized Double blind 63 Bln Share Buyback 63 diclofenac sodium 63 Requip XL 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 Oxybutynin 63 Benign Prostatic Hyperplasia 63 Simvastatin Tablets 63 Drug Submission 63 ELADUR ™ 63 Vfend